Cyclic oligoadenylate (cOA) secondary messengers are generated by type III CRISPR systems in response to viral infection. cOA allosterically activates the CRISPR ancillary ribonucleases Csx1/Csm6, which degrade RNA non-specifically using a HEPN (Higher Eukaryotes and Prokaryotes, Nucleotide binding) active site. This provides effective immunity but can also lead to growth arrest in infected cells, necessitating a means to deactivate the ribonuclease once viral infection has been cleared. In the crenarchaea, dedicated ring nucleases degrade cA4 (cOA consisting of 4 AMP units), but the equivalent enzyme has not been identified in bacteria. We demonstrate that, in Thermus thermophilus HB8, the uncharacterized protein TTHB144 is a cA4-activated...
Prokaryotic CRISPR-Cas systems provide an RNA-guided mechanism for genome defense against mobile gen...
Bacterial and archaeal CRISPR-Cas systems provide RNA-guided immunity against genetic invaders such ...
Antiviral defence systems that exhibit high specificity, such as prokaryotic CRISPR-Cas, are widely ...
This work was funded by a grant from the Biotechnology and Biological Sciences Research Council (Gra...
Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) second messengers in response to vira...
The type III CRISPR-Cas systems provide immunity against invading nucleic acids through the coordina...
The CRISPR system in bacteria and archaea provides adaptive immunity against mobile genetic elements...
This work was funded by grants from the Biotechnology and Biological Sciences Research Council (REF ...
Type III CRISPR systems detect foreign RNA and activate the cyclase domain of the Cas10 subunit, gen...
Cells and organisms have a wide range of mechanisms to defend against infection by viruses and other...
The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes. On bind...
CRISPR-Cas systems provide prokaryotes with RNA-based adaptive immunity against viruses and plasmids...
In prokaryotes, CRISPR-Cas immune systems recognise and cleave foreign nucleic acids to defend again...
<p>CRISPR-Cas systems provide prokaryotes with RNA-based adaptive immunity against viruses and plasm...
Type III CRISPR-Cas prokaryotic immune systems provide anti-viral and anti-plasmid immunity via a du...
Prokaryotic CRISPR-Cas systems provide an RNA-guided mechanism for genome defense against mobile gen...
Bacterial and archaeal CRISPR-Cas systems provide RNA-guided immunity against genetic invaders such ...
Antiviral defence systems that exhibit high specificity, such as prokaryotic CRISPR-Cas, are widely ...
This work was funded by a grant from the Biotechnology and Biological Sciences Research Council (Gra...
Type III CRISPR systems synthesise cyclic oligoadenylate (cOA) second messengers in response to vira...
The type III CRISPR-Cas systems provide immunity against invading nucleic acids through the coordina...
The CRISPR system in bacteria and archaea provides adaptive immunity against mobile genetic elements...
This work was funded by grants from the Biotechnology and Biological Sciences Research Council (REF ...
Type III CRISPR systems detect foreign RNA and activate the cyclase domain of the Cas10 subunit, gen...
Cells and organisms have a wide range of mechanisms to defend against infection by viruses and other...
The CRISPR system provides adaptive immunity against mobile genetic elements in prokaryotes. On bind...
CRISPR-Cas systems provide prokaryotes with RNA-based adaptive immunity against viruses and plasmids...
In prokaryotes, CRISPR-Cas immune systems recognise and cleave foreign nucleic acids to defend again...
<p>CRISPR-Cas systems provide prokaryotes with RNA-based adaptive immunity against viruses and plasm...
Type III CRISPR-Cas prokaryotic immune systems provide anti-viral and anti-plasmid immunity via a du...
Prokaryotic CRISPR-Cas systems provide an RNA-guided mechanism for genome defense against mobile gen...
Bacterial and archaeal CRISPR-Cas systems provide RNA-guided immunity against genetic invaders such ...
Antiviral defence systems that exhibit high specificity, such as prokaryotic CRISPR-Cas, are widely ...